This symposium is intended for all those who are confronted during their daily practice with cardiac patients suffering from disabling or life-threatening arrhythmias or conduction disturbances, or heart failure aggravated by these conditions.
Accredited 15 CME credit hours by the EBAC
Since the 90’s clinical electrophysiology has seen an amazing development. After introduction of radiofrequency (RF) ablation, new imaging and mapping techniques have emerged. Accessory pathways, AV nodal re-entrant tachycardia and ventricular arrhythmias can all be effectively ablated. We have paid a lot of attention to therapy modalities with a better profile than RF: cryotherapy is one example, which makes AV block in AVNRT non-existent…
Atrial fibrillation remains the major problem in clinical arrhythmology: after the major trials on rate and rhythm control, strategic decisions remain as difficult as ever. The fact that thrombo-embolic complications occur with both strategies implies that anti coagulation remains a very important topic. New strategies have emerged in this area as well and are now introduced, making frequent blood check-ups no longer necessary. Catheter ablation, with pulmonary vein isolation is one of the cornerstones of effective treatment for paroxysmal AF. ICD technology, with improving detection algorithms, painless therapy and combined with multisite pacing finds broader applications. Prophylactic implantation is now established with subcutaneous, “lead-less” approaches as a new possibility. Risk profiling remains important; avoiding implantation in patients who would not benefit is another item to be considered. Attention will be given to the genetic background, anti arrhythmic drug therapy and follow-up of patients with heart failure and complex arrhythmias.